Definitive Contract 75F40120C00171
Award Date
9/29/20
Potential Completion Date
9/29/21
Potential Value
$250K
Federal Agency
Food and Drug Administration
Awardee
Hartford Hospital
Ultimate Awardee
Hartford Healthcare Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Definitive Contract to Hartford Hospital, a non-profit hospital in Hartford, Connecticut, with a potential value of $249,794.00. The contract is for research related to "Metallo-B-Lactamase Resistance in Enterobacterales: Is It Time to Rethink Our In Vitro Assessment Tools?". This contract was issued under a Broad Agency Announcement (BAA) that solicits advanced research and...
The Department of Health and Human Services Food and Drug Administration awarded a $407,720 definitive contract to Hartford Hospital. The contract is for ex vivo modeling, simulation, and in vivo pharmacokinetic validation to guide antimicrobial dosing recommendations for patients on continuous renal replacement therapy. The contract has a start date of September 9, 2022 and end date of September 29, 2024, and utilizes a firm fixed price pricing structure. The place of performance is Hartford,...
The Department of Health and Human Services Food and Drug Administration awarded a $249,999.00 definitive contract to Hartford Hospital, a non-profit hospital organization, to conduct research and development in support of regulatory science and innovation. This contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science for fiscal year 2021, which solicits proposals across eight areas of regulatory science to modernize FDA functions. The contract does not have...
This is a $539,764.16 firm fixed price purchase order awarded by the Department of the Navy's Bureau of Medicine and Surgery to Hartford Hospital, a non-profit 830-bed hospital in Hartford, Connecticut. The contract is for emergency medical simulation training services, with a performance period through May 14, 2023. Hartford Hospital has previously conducted research for the Food and Drug Administration and provided clinical services in support of multi-site studies funded by the National...
This is a Firm Fixed Price definitive contract awarded by the Naval Supply Systems Command (NAVSUP) to Hartford Hospital, a non-profit healthcare institution in Hartford, Connecticut. The contract is for $3,900.00 and provides emergency medical training classes. The contract has an ultimate completion date of May 1, 2025 and was awarded on April 30, 2025. There is no set-aside designation indicated for this contract. Hartford Hospital has previously received federal grant awards, primarily...
This federal contract award, valued at $450,714.35, was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Hartford Hospital, a non-profit healthcare institution and subsidiary of Hartford Healthcare Corporation. The contract is for emergency medical simulation training services and does not have a set-aside designation. This award demonstrates Hartford Hospital's expertise in providing advanced medical research and simulation services to federal...
This $291,142 firm fixed price prime contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the Institute For Clinical Pharmacodynamics, Inc. to conduct research on updating susceptibility guidance for the oral antibiotics sulfamethoxazole-trimethoprim. The contract supports the agency's efforts to develop modernized susceptibility guidance using pharmacometric approaches. No set-aside designation was used for this award. The Institute For Clinical...
This is a definitive contract awarded by the Department of Health and Human Services' Food and Drug Administration to Yale University, a private non-profit university, with a potential value of $282,074.82. The contract is not designated as a set-aside award. Under this contract, Yale University is partnering with Mayo Clinic, another private non-profit academic medical center, as a subcontractor. The subcontract work involves implementing multiple Common Data Models (CDMs) at two academic...
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the University of Connecticut for "Assessing Long-Acting Injectable Formulations Using In Vivo Imaging". The potential value of the contract is $1,131,742.00 and it has a completion date of September 29, 2024. The contract is not set aside for a specific business category. Under this contract, the University of Connecticut is conducting research and analysis on...
This is a $219,991 cost-no-fee definitive contract awarded by the Food and Drug Administration (FDA) to the University of Connecticut (UConn) to conduct research on the "Continuous Manufacturing of Liposomes: Materials Understanding and Process Control." The contract is part of the FDA's broader program on continuous manufacturing of liposomes, a type of drug delivery system. UConn, a leading public research institution, will leverage its expertise in materials science, engineering,...